GlassScriptPhysician profile
Samuel J Forzley
NPI 1144230392
$2,650.99
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $366 · 2021: $362 · 2022: $531 · 2023: $510 · 2024: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $653.74 | 2019-2024 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb Americas INC. | $289.15 | 2022-2024 | Infuse, Biotrue One Day, Lotemax Sm |
| Novartis Pharmaceuticals Corporation | $271.32 | 2019-2023 | |
| Coopervision INC. | $211.13 | 2019-2024 | Myday Contact Lens |
| Biotissue Holdings INC. | $198.17 | 2019-2024 | |
| Johnson & Johnson Vision Care, INC. | $193.76 | 2021-2024 | Acuvue |
| Abbvie INC. | $128.70 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.87 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $100.40 | 2019-2023 | Cequa |
| Abb Con-Cise Optical Group LLC | $84.34 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Oyster Point Pharma, INC. | $75.38 | 2022-2024 | Ryzumvi, Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $74.88 | 2024 | Xdemvy |
| Shire North American Group INC | $66.38 | 2019 | |
| Eyevance Pharmaceuticals LLC | $42.64 | 2019 | |
| Allergan, INC. | $32.16 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $28.09 | 2019 | |
| Sight Sciences, INC. | $26.84 | 2021 | |
| Lombart Brothers, INC. | $20.00 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tearlab Corp | $15.64 | 2022 | |
| Synergeyes, INC. | $11.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Forzley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.